| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/20/2004 | US6764823 Antimicrobial methods and materials |
| 07/20/2004 | US6764689 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 07/20/2004 | US6764687 Live attenuated bacteria for use in a vaccine |
| 07/20/2004 | US6764686 Modified immunogenic pneumolysin compositions as vaccines |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | US6764681 Lymphocyte antibodies |
| 07/20/2004 | US6764679 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 07/20/2004 | US6764677 Tango 294, a lipase-like protein |
| 07/20/2004 | US6764676 Attenuated fiv-141 virus with deletion mutation in the env gene; vaccines; replicates upon entry to host cell |
| 07/20/2004 | CA2253374C Novel osp-c derived peptide fragments |
| 07/20/2004 | CA2246456C Lipids and their use, for example, in liposomes |
| 07/20/2004 | CA2103148C Determination of motifs of peptides on mhc molecules |
| 07/20/2004 | CA2096159C Peptides that induce antibodies which neutralize genetically divergent hiv-1 isolates |
| 07/20/2004 | CA2036733C Immunodominant acetylcholine receptor peptides useful for t-helper cell sensitization |
| 07/15/2004 | WO2004058996A2 Method for controlling processes based on microbial interaction |
| 07/15/2004 | WO2004058988A2 Binding agents which inhibit myostatin |
| 07/15/2004 | WO2004058986A2 Btl-ii nucleic acids, proteins, and antibodies |
| 07/15/2004 | WO2004058981A1 Highly efficient gene targeting vector and gene targeting method toward epithelial cell line |
| 07/15/2004 | WO2004058980A2 Plants having modified growth characteristics and a method for making the same |
| 07/15/2004 | WO2004058977A1 Chimeric protein for the screening of agonists and antagonists of cell signalling pathways that are dependent on g-protein-coupled receptors |
| 07/15/2004 | WO2004058975A1 Method of enhancing tolerance to environmental stresses of plant |
| 07/15/2004 | WO2004058974A1 A method of drug screening to select agonists or antagonists of g protein coupled receptors (gpcr). |
| 07/15/2004 | WO2004058973A1 Fluorescent proteins from copepoda species and methods for using same |
| 07/15/2004 | WO2004058972A1 Human autoantigens and use thereof |
| 07/15/2004 | WO2004058971A1 Human cancer-relating genes, the products encoded thereby and applications thereof |
| 07/15/2004 | WO2004058970A1 Adiponectin promoter and use thereof |
| 07/15/2004 | WO2004058964A1 Method of inducing homologous recombination of somatic cell |
| 07/15/2004 | WO2004058963A2 A novel gene osisap1 of rice confers tolerance to stresses and a method thereof |
| 07/15/2004 | WO2004058953A1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 07/15/2004 | WO2004058949A2 Wnt-1 inhibitory factor-1 (wif-1) molecules and uses thereof |
| 07/15/2004 | WO2004058944A2 Product quality enhancement in mammalian cell culture processes for protein production |
| 07/15/2004 | WO2004058819A2 Crystalline liver x receptor beta protein |
| 07/15/2004 | WO2004058818A2 Spliced variants of lgr6 |
| 07/15/2004 | WO2004058817A1 Novel proteins and use thereof |
| 07/15/2004 | WO2004058816A2 Inclusion bodies for the oral vaccination of animals |
| 07/15/2004 | WO2004058815A2 Centrosome-associated protein and applications thereof |
| 07/15/2004 | WO2004058813A2 Peptides having a high cysteine content |
| 07/15/2004 | WO2004058811A2 Crystal structures of yhhf polypeptides |
| 07/15/2004 | WO2004058809A2 Novel essential bacterial polypeptides |
| 07/15/2004 | WO2004058808A2 Dna vaccines against hantavirus infections |
| 07/15/2004 | WO2004058807A2 Mhc class i restricted t-cell stimulating peptides from hepatitis b virus |
| 07/15/2004 | WO2004058806A2 Inclusion bodies as antigens for the oral vaccination of animals against csfv |
| 07/15/2004 | WO2004058805A2 T cell activating gene |
| 07/15/2004 | WO2004058804A1 Peptides and therapeutic uses thereof |
| 07/15/2004 | WO2004058803A2 Peptides that bind of the vegfr-2 |
| 07/15/2004 | WO2004058802A1 Peptides that bind to the heparin binding domian of vegf and vegfr-2 |
| 07/15/2004 | WO2004058801A2 Modified vaccinia ankara expressing p53 in cancer immunotherapy |
| 07/15/2004 | WO2004058800A2 Mammalian cell culture processes for protein production |
| 07/15/2004 | WO2004058798A2 Antimicrobial peptides |
| 07/15/2004 | WO2004058309A1 Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof |
| 07/15/2004 | WO2004058307A1 Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof |
| 07/15/2004 | WO2004058306A1 Tumor supression through bicistronic co-expression of p53 and p14arf |
| 07/15/2004 | WO2004058291A1 Modified hemoglobin and methods of making same |
| 07/15/2004 | WO2004058290A1 Inhibition of hiv replication by expression of late domain peptides in target cells |
| 07/15/2004 | WO2004058288A1 Novel therapeutic targets in cancer |
| 07/15/2004 | WO2004058189A2 Chemokine antagonists and uses thereof |
| 07/15/2004 | WO2004058188A2 Vaccine compositions and methods |
| 07/15/2004 | WO2004058181A2 Vmp-like sequences of pathogenic borrelia species and strains |
| 07/15/2004 | WO2004058177A2 Crystals and structures of spleen tyrosine kinase sykkd |
| 07/15/2004 | WO2004058171A2 Antibodies against gpr64 and uses thereof |
| 07/15/2004 | WO2004058169A2 Mag derivatives, compositions, and methods of use thereof |
| 07/15/2004 | WO2004058166A2 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 07/15/2004 | WO2004058165A2 Saposing c and receptors as targets for treatment of benign and malignant disorders |
| 07/15/2004 | WO2004058146A2 Novel compositions and methods in cancer |
| 07/15/2004 | WO2004058088A2 Bacteriophage-encoded antibacterial enzyme for the treatment and prevention of gingivitis and root surface caries |
| 07/15/2004 | WO2004058052A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 07/15/2004 | WO2004057946A2 Method for altering the content of reserve substances in plants |
| 07/15/2004 | WO2004057941A2 RECESSIVE PLANT VIRAL RESISTANCE RESULTS FROM MUTATIONS IN TRANSLATION INITIATION FACTOR eIF4E |
| 07/15/2004 | WO2004057940A2 Canine dioxin/aryl hydrocarbon receptor sequences |
| 07/15/2004 | WO2004050124A3 Chimaeric molecules |
| 07/15/2004 | WO2004047853A3 Methods for the treatment of chronic pain and compositions therefor |
| 07/15/2004 | WO2004044007A8 Production of ubiquitin fusion proteins |
| 07/15/2004 | WO2004042350A3 Using amines or amino acids as mobile phase modifiers in chromatography |
| 07/15/2004 | WO2004041853A3 Hcv vaccine compositions comprising e1 and ns3 peptides |
| 07/15/2004 | WO2004041076A3 Methods of detecting colorectal cancer |
| 07/15/2004 | WO2004035626A8 Alpha macroglobulin protein family members |
| 07/15/2004 | WO2004034956A3 8-plasmid method with mutated ha gene for producing an influenza vaccine |
| 07/15/2004 | WO2004033634A3 Transgenic cells transfected with pituitary tumor transforming gene (pttg) expression vectors and uses therefor |
| 07/15/2004 | WO2004032599A3 Novel immunogenic proteins of leptospira |
| 07/15/2004 | WO2004031412A3 Method for diagnosing pancreatic cancer |
| 07/15/2004 | WO2004031357A3 Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors |
| 07/15/2004 | WO2004031224A3 Hbv mutations associated with reduced susceptibility to adefovir |
| 07/15/2004 | WO2004030630A3 Focal calcium channel modulation |
| 07/15/2004 | WO2004029280A3 Anti-hla assay and methods |
| 07/15/2004 | WO2004028239A3 Mammal model for autoimmune diseases with dysfunction of socs-1 gene |
| 07/15/2004 | WO2004027048A3 High titer recombinant aav production |
| 07/15/2004 | WO2004026260A3 Prophylactic and therapeutic hiv aptamers |
| 07/15/2004 | WO2004024879A3 RORs AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 07/15/2004 | WO2004022593A3 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 07/15/2004 | WO2004020609A3 Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection |
| 07/15/2004 | WO2004020595A8 Novel human polypeptides encoded by polynucleotides |
| 07/15/2004 | WO2004016653A3 Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) or human neutrophil elastase |
| 07/15/2004 | WO2004012673A3 Methods and reagents relating to inflammation and apoptosis |
| 07/15/2004 | WO2004007664A3 Nucleic acid vectors |
| 07/15/2004 | WO2004005478A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | WO2004005322A3 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 07/15/2004 | WO2004003160A3 Use of adhesion molecules as bond stress-enhanced nanoscale binding switches |
| 07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
| 07/15/2004 | WO2003100022A3 Methods and dna constructs for high yield production of polypeptides |
| 07/15/2004 | WO2003093431A3 Ablated slam-dependent entry |